SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Block listing update

8 Oct 2019 10:00

RNS Number : 1338P
Porvair PLC
08 October 2019
 

8 October 2019

 

Porvair plc

("Porvair" or the "Group")

 

Block listing update

 

Porvair, the specialist filtration and environmental technologies group, announces that an application has been made to the Financial Conduct Authority ("FCA") and London Stock Exchange ("LSE") in order to increase an existing block listing of ordinary shares of 2 pence per share ("Ordinary Shares") used to satisfy the issue of shares pursuant to exercises of options under the Porvair plc SAYE Share Option Plan 2014 ("SAYE Plan").

 

Application has been made for the admission of 510,269 new Ordinary Shares to the premium listing segment of the Official List of the FCA and to trading on the main market of the LSE (together "Admission"). New Ordinary Shares issued under the block listing will rank pari passu in all respect with the existing Ordinary Shares of the Company. It is expected that Admission will become effective on 10 October 2019.

 

In addition, the Company currently has 21,925 new Ordinary Shares admitted (but not yet issued) under an existing block listing that relate to the Porvair Long Term Share Plan 2008 (the "LTSP"). All share issues expected to be required in order to satisfy the exercise of options under the LTSP have been made and, as a result, the associated LTSP block listing will be cancelled. The Company made 151,375 allotments under the LTSP since the last block listing return. The block listing return, as at 7 October 2019 is set out below.

 

The Company's issued share capital will not change as a result of the changes to the block listings set out above.

 

Total Voting Rights

The Company's issued share capital consists of 45,843,599 Ordinary Shares with voting rights. Therefore, the total number of voting rights in the Company will be 45,843,599. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the disclosure guidance issued by the FCA and the transparency rules made by the FCA under section 89A(1) of the Financial Services and Markets Act 2000, as amended.

 

For more information, contact:

 

Porvair plc

 

Ben Stocks, Chief Executive

01553 765 500

Chris Tyler, Group Finance Director

01553 765 500

 

 

Buchanan

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

Name of applicant:

Porvair plc

Name of scheme:

Porvair Long Term Share Plan 2008

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

173,300

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(151,375)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

21,925

 

Name of applicant:

Porvair plc

Name of scheme:

Porvair plc SAYE Share Option Plan 2014

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

129,561

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

510,269

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(51,049)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

588,781

 

 

Name of contact:

Chris Tyler (Group Finance Director)

Telephone number of contact:

01553 765 500

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSUWVWRKNARRRA
Date   Source Headline
9th Dec 20217:00 amRNSPre-close trading update and Notice of Results
23rd Nov 202112:30 pmRNSHolding(s) in Company
5th Nov 20214:40 pmRNSSecond Price Monitoring Extn
5th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Oct 20214:40 pmRNSSecond Price Monitoring Extn
8th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Sep 20214:41 pmRNSSecond Price Monitoring Extn
27th Sep 20214:35 pmRNSPrice Monitoring Extension
16th Sep 20213:31 pmRNSDirector/PDMR Shareholding
14th Sep 20217:00 amRNSNine Month Trading Update
11th Aug 20214:41 pmRNSSecond Price Monitoring Extn
11th Aug 20214:35 pmRNSPrice Monitoring Extension
10th Aug 20214:40 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20217:00 amRNSBlock listing Interim Review
5th Jul 20217:00 amRNSHalf Year Results 2021
30th Jun 20217:00 amRNSTotal Voting Rights
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:35 pmRNSPrice Monitoring Extension
10th May 20214:40 pmRNSSecond Price Monitoring Extn
10th May 20214:36 pmRNSPrice Monitoring Extension
21st Apr 20212:40 pmRNSGrant of LTSP awards
20th Apr 202112:30 pmRNSAGM resolutions and Board changes
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 20214:28 pmRNSTotal Voting Rights
17th Mar 20214:57 pmRNSHolding(s) in Company
16th Mar 20212:01 pmRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20213:27 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSAcquisition of Kbiosystems Limited
22nd Feb 20213:00 pmRNSHolding(s) in Company
19th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 20214:36 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSBlock listing Interim Review
8th Feb 20217:00 amRNSTotal Voting Rights
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
3rd Feb 20219:42 amRNSHolding(s) in Company
2nd Feb 20217:00 amRNSGrant of LTSP awards
1st Feb 20217:00 amRNSFinal Results
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:35 pmRNSPrice Monitoring Extension
30th Dec 20203:30 pmRNSHolding(s) in Company
30th Dec 20203:30 pmRNSHolding(s) in Company
9th Dec 20203:47 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSPre-close trading update
23rd Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.